MTOR and cancer: Accepting cancer biology is complex and knowledge of the behaviour of this genetic syndrome is limited to a few cases reported worldwide, the authors believe that renal transplantation is the best treatment option for this young patient and probably will opt for a post-transplant immunosuppressive maintenance scheme with a mTOR inhibitor.